Demand for Upstream Bioprocessing Equipment in USA

Future Market Insights

Key Insight

The demand for upstream bioprocessing equipment in USA is projected to grow from USD 1.8 billion in 2025 to USD 2.9 billion by 2035, at a CAGR of 4.8%. Mammalian cell will dominate with a 57.9% market share, while bioreactors will lead the processing type segment with a 66.8% share.

November 26, 2025

Anurag Sharma

250 Pages

Cite this Report

Demand for Upstream Bioprocessing Equipment in USA

https://www.futuremarketinsights.com/reports/united-states-upstream-bioprocessing-equipment-market

License

Buy Now

Summary ToC Companies

Key Players

BIOZEEN
Boehringer Ingelheim Pharma GmbH & Co.KG
General Electric
Katalyst Bio Engineering
Merck KGaA
Thermo Fisher Scientific Inc.

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Demand for Upstream Bioprocessing Equipment in USA

Key Players

Similar Industry Reports